Donald H. Picker's most recent trade in Moleculin Biotech Inc was a trade of 1,766 Common Stock done . Disclosure was reported to the exchange on June 20, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2025 | 1,766 | 10,582 (0%) | 0% | - | Common Stock | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2025 | 1,766 | 104,258 | - | - | Restricted Stock Units | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2025 | 1,078 | 106,024 | - | - | Restricted Stock Units | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2025 | 1,078 | 9,079 (0%) | 0% | - | Common Stock | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.27 per share. | 20 Jun 2025 | 430 | 10,152 (0%) | 0% | 0.3 | 115 | Common Stock |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.27 per share. | 20 Jun 2025 | 263 | 8,816 (0%) | 0% | 0.3 | 70 | Common Stock |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2024 | 40,000 | 66,358 | - | - | Stock option (right to buy) | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2024 | 35,000 | 101,358 | - | - | Restricted Stock Units | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2024 | 5,744 | 107,102 | - | - | Performance Based Restricted Stock Units | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2024 | 1,766 | 8,525 (0%) | 0% | - | Common Stock | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2024 | 1,766 | 26,358 | - | - | Restricted Stock Units | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.74 per share. | 22 Jun 2024 | 524 | 8,001 (0%) | 0% | 3.7 | 1,960 | Common Stock |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 1,078 | 7,079 (0%) | 0% | - | Common Stock | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 1,078 | 28,124 | - | - | Restricted Stock Units | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.78 per share. | 20 Jun 2024 | 320 | 6,759 (0%) | 0% | 3.8 | 1,210 | Common Stock |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 105,938 | 437,948 | - | - | Restricted Stock Units | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 100,000 | 332,010 | - | - | Stock option (right to buy) | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 16,167 | 94,273 (0%) | 0% | - | Common Stock | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 16,167 | 232,010 | - | - | Restricted Stock Units | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.57 per share. | 16 Jun 2023 | 4,267 | 90,006 (0%) | 0% | 0.6 | 2,432 | Common Stock |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2022 | 65,000 | 183,510 | - | - | Stock option (right to buy) | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2022 | 64,667 | 248,177 | - | - | Restricted Stock Units | |
Moleculin Biotech Inc | Donald H. Picker | Chief Science Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 62,676 | 118,510 | - | - | Stock option (right to buy) |